179 related articles for article (PubMed ID: 1888023)
1. Determination of platelet-activating factor and alkyl-ether phospholipids by gas chromatography-mass spectrometry via direct derivatization.
Balazy M; Braquet P; Bazan NG
Anal Biochem; 1991 Jul; 196(1):1-10. PubMed ID: 1888023
[TBL] [Abstract][Full Text] [Related]
2. Quantitation of lyso-platelet activating factor molecular species from human neutrophils by mass spectrometry.
Haroldsen PE; Clay KL; Murphy RC
J Lipid Res; 1987 Jan; 28(1):42-9. PubMed ID: 3104521
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of platelet activating factor treated with pentafluorobenzoyl chloride using gas chromatography/negative ion chemical ionization mass spectrometry.
Shindo K; Hashimoto Y
Drugs Exp Clin Res; 1991; 17(7):343-9. PubMed ID: 1794300
[TBL] [Abstract][Full Text] [Related]
4. Molecular heterogeneity of PAF in normal human mixed saliva: quantitative mass spectral analysis after direct derivatization of PAF with pentafluorobenzoic anhydride.
Woodard DS; Mealey BL; Lear CS; Satsangi RK; Prihoda TJ; Weintraub ST; Pinckard RN; McManus LM
Biochim Biophys Acta; 1995 Nov; 1259(2):137-47. PubMed ID: 7488633
[TBL] [Abstract][Full Text] [Related]
5. Quantification of distinct molecular species of the 2-lyso metabolite of platelet-activating factor by gas chromatography-negative-ion chemical ionization mass spectrometry.
Turk J; Bohrer A; Stump WT; Ramanadham S; Mangino MJ
J Chromatogr; 1992 Mar; 575(2):183-96. PubMed ID: 1629294
[TBL] [Abstract][Full Text] [Related]
6. Nasal allergen challenge generates 1-0-hexadecyl-2-lyso-sn-glycero-3-phosphocholine.
Shin MH; Averill FJ; Hubbard WC; Chilton FH; Baroody FM; Liu MC; Naclerio RM
Am J Respir Crit Care Med; 1994 Mar; 149(3 Pt 1):660-6. PubMed ID: 8118633
[TBL] [Abstract][Full Text] [Related]
7. Analysis of lyso-platelet activating factor by negative ion gas chromatography/mass spectrometry of the nitrobenzal acetal derivatives.
Mallet AI
Biomed Environ Mass Spectrom; 1988 Oct; 16(1-12):207-10. PubMed ID: 3242671
[TBL] [Abstract][Full Text] [Related]
8. A novel method for the analysis of PAF and alkyl-ether phospholipids by mass spectrometry.
Balazy M; Cluzel J; Bazan NG
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():323-6. PubMed ID: 1825562
[No Abstract] [Full Text] [Related]
9. Development of a high-performance liquid chromatographic-mass spectrometric technique, with an ionspray interface, for the determination of platelet-activating factor (PAF) and lyso-PAF in biological samples.
Silvestro L; Da Col R; Scappaticci E; Libertucci D; Biancone L; Camussi G
J Chromatogr; 1993 Sep; 647(2):261-9. PubMed ID: 8227267
[TBL] [Abstract][Full Text] [Related]
10. Platelet-aggregating effects of platelet-activating factor-like phospholipids formed by oxidation of phosphatidylcholines containing an sn-2-polyunsaturated fatty acyl group.
Tanaka T; Iimori M; Tsukatani H; Tokumura A
Biochim Biophys Acta; 1994 Jan; 1210(2):202-8. PubMed ID: 8280771
[TBL] [Abstract][Full Text] [Related]
11. Isotopic exchange during derivatization of platelet activating factor for gas chromatography-mass spectrometry.
Haroldsen PE; Gaskell SJ; Weintraub ST; Pinckard RN
J Lipid Res; 1991 Apr; 32(4):723-9. PubMed ID: 1856615
[TBL] [Abstract][Full Text] [Related]
12. A novel method for the analysis of platelet-activating factor: direct derivatization of glycerophospholipids.
Satsangi RK; Ludwig JC; Weintraub ST; Pinckard RN
J Lipid Res; 1989 Jun; 30(6):929-37. PubMed ID: 2794783
[TBL] [Abstract][Full Text] [Related]
13. A competitive receptor binding assay for platelet-activating factor (PAF): quantification of PAF in rat brain.
Tiberghien C; Laurent L; Junier MP; Dray F
J Lipid Mediat; 1991; 3(3):249-66. PubMed ID: 1773028
[TBL] [Abstract][Full Text] [Related]
14. Analysis of platelet-activating factor by GC-MS after direct derivatization with pentafluorobenzoyl chloride and heptafluorobutyric anhydride.
Weintraub ST; Lear CS; Pinckard RN
J Lipid Res; 1990 Apr; 31(4):719-25. PubMed ID: 2351876
[TBL] [Abstract][Full Text] [Related]
15. Quantification of distinct molecular species of platelet activating factor in ulcerative colitis.
Thyssen E; Turk J; Bohrer A; Stenson WF
Lipids; 1996 Mar; 31 Suppl():S255-9. PubMed ID: 8729129
[TBL] [Abstract][Full Text] [Related]
16. Detection of lyso-platelet-activating factor by high-performance liquid chromatography after derivatisation with fluorescent fatty acids.
Salari H; Eigendorf GK
J Chromatogr; 1990 May; 527(2):303-14. PubMed ID: 2387879
[TBL] [Abstract][Full Text] [Related]
17. Translocation of exogenous platelet-activating factor and its lyso-compound through plasma membranes is a rate-limiting step for their metabolic conversions into alkylacylglycerophosphocholines in rabbit platelets and guinea-pig leukocytes.
Tokumura A; Tsutsumi T; Yoshida J; Tsukatani H
Biochim Biophys Acta; 1990 May; 1044(1):91-100. PubMed ID: 2340312
[TBL] [Abstract][Full Text] [Related]
18. Release of 1-O-alkylglyceryl 3-phosphorylcholine, O-deacetyl platelet-activating factor, from leukocytes: chemical ionization mass spectrometry of phospholipids.
Polonsky J; Tencé M; Varenne P; Das BC; Lunel J; Benveniste J
Proc Natl Acad Sci U S A; 1980 Dec; 77(12):7019-23. PubMed ID: 6938950
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of platelet activating factor using fast atom bombardment/tandem mass spectrometry.
Haroldsen PE; Gaskell SJ
Biomed Environ Mass Spectrom; 1989 Jun; 18(6):439-44. PubMed ID: 2504312
[TBL] [Abstract][Full Text] [Related]
20. Production of paf-acether by human epidermal cells.
Michel L; Denizot Y; Thomas Y; Jean-Louis F; Heslan M; Benveniste J; Dubertret L
J Invest Dermatol; 1990 Nov; 95(5):576-81. PubMed ID: 2230220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
